Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ammar Sukari

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Oral Oncology|October 23, 2019
Immune checkpoint inhibitors: For how long do we need to release the brakes to achieve the optimum acceleration of immune-mediated anti-tumor response?Ammar Sukari, Misako Nagasaka
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
<i>EGFR</i>-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine: Importance of Germline <i>EGFR</i> T790M TestingAmmar Sukari, Misako Nagasaka, Erin Wakeling
Critical Reviews in Oncology/Hematology|March 18, 2019
Unleash the power of the mighty T cells-basis of adoptive cellular therapyAmmar Sukari, Nadine Abdallah, Misako Nagasaka
Oral Oncology|April 2, 2018
Responses in patients receiving sequential paclitaxel post progression on PD1 inhibitorsAmmar Sukari, Misako Nagasaka, Nadine Abdallah
Clinical Case Reports|July 11, 2018
Is this really just "fatigue"? A case series of immune-related central adrenal insufficiency secondary to immune checkpoint inhibitorsMisako Nagasaka, Nadine Abdallah, Julie Samantray, et al.
Head & Neck|February 17, 2021
Quality metrics for head and neck cancer treated with definitive radiotherapy and/or chemotherapyRadwa Elsharawi, Eric Antonucci, Ammar Sukari, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 28, 2021
Incidence of Second Primary Lung Cancer After Low-Dose Computed Tomography vs Chest Radiography Screening in Survivors of Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical TrialJohn D Cramer, Jordan Grauer, Ammar Sukari, et al.
Avicenna Journal of Medicine|July 5, 2013
Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literatureBelal Firwana, Bassel Atassi, Rim Hasan, et al.
Clinical Lung Cancer|September 7, 2020
PLEKHH2-ALK: A Novel In-frame Fusion With Durable Response to Alectinib: Utilizing RNA Sequencing in Search for Hidden Gene Fusions Susceptible to Targeted TherapyMisako Nagasaka, Amanda Fisher, Tahmida Chowdhury, et al.
Anticancer Research|October 30, 2016
Cancer Immunology and ImmunotherapyAmmar Sukari, Misako Nagasaka, Ameer Al-Hadidi, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Oral Oncology|October 23, 2019
Immune checkpoint inhibitors: For how long do we need to release the brakes to achieve the optimum acceleration of immune-mediated anti-tumor response?Ammar Sukari, Misako Nagasaka
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
<i>EGFR</i>-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine: Importance of Germline <i>EGFR</i> T790M TestingAmmar Sukari, Misako Nagasaka, Erin Wakeling
Critical Reviews in Oncology/Hematology|March 18, 2019
Unleash the power of the mighty T cells-basis of adoptive cellular therapyAmmar Sukari, Nadine Abdallah, Misako Nagasaka
Oral Oncology|April 2, 2018
Responses in patients receiving sequential paclitaxel post progression on PD1 inhibitorsAmmar Sukari, Misako Nagasaka, Nadine Abdallah
Clinical Case Reports|July 11, 2018
Is this really just "fatigue"? A case series of immune-related central adrenal insufficiency secondary to immune checkpoint inhibitorsMisako Nagasaka, Nadine Abdallah, Julie Samantray, et al.
Head & Neck|February 17, 2021
Quality metrics for head and neck cancer treated with definitive radiotherapy and/or chemotherapyRadwa Elsharawi, Eric Antonucci, Ammar Sukari, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 28, 2021
Incidence of Second Primary Lung Cancer After Low-Dose Computed Tomography vs Chest Radiography Screening in Survivors of Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical TrialJohn D Cramer, Jordan Grauer, Ammar Sukari, et al.
Avicenna Journal of Medicine|July 5, 2013
Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literatureBelal Firwana, Bassel Atassi, Rim Hasan, et al.
Clinical Lung Cancer|September 7, 2020
PLEKHH2-ALK: A Novel In-frame Fusion With Durable Response to Alectinib: Utilizing RNA Sequencing in Search for Hidden Gene Fusions Susceptible to Targeted TherapyMisako Nagasaka, Amanda Fisher, Tahmida Chowdhury, et al.
Anticancer Research|October 30, 2016
Cancer Immunology and ImmunotherapyAmmar Sukari, Misako Nagasaka, Ameer Al-Hadidi, et al.
Pageof 8